Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors.

Autor: Golinelli G; Department of Medical and Surgical Sciences for Children and Adults, Division of Oncology, University-Hospital of Modena and Reggio Emilia, Modena, Italy. giulia.golinelli@unimore.it., Grisendi G; Department of Medical and Surgical Sciences for Children and Adults, Division of Oncology, University-Hospital of Modena and Reggio Emilia, Modena, Italy.; Rigenerand Srl, Medolla, Modena, Italy., Prapa M; Department of Medical and Surgical Sciences for Children and Adults, Division of Oncology, University-Hospital of Modena and Reggio Emilia, Modena, Italy., Bestagno M; International Centre for Genetic Engineering and Biotechnology, Trieste, Italy., Spano C; Department of Medical and Surgical Sciences for Children and Adults, Division of Oncology, University-Hospital of Modena and Reggio Emilia, Modena, Italy.; Rigenerand Srl, Medolla, Modena, Italy., Rossignoli F; Department of Medical and Surgical Sciences for Children and Adults, Division of Oncology, University-Hospital of Modena and Reggio Emilia, Modena, Italy., Bambi F; Cell Factory Meyer, 'A. Meyer' University Children's Hospital, Florence, Italy., Sardi I; Neuro-Oncology Unit, Department of Pediatric Oncology, Meyer Children's University Hospital, Florence, Italy., Cellini M; Onco-Hematology Pediatric Unit, Department of Medical and Surgical Sciences for Mothers, Children and Adults, University-Hospital of Modena and Reggio Emilia, Modena, Italy., Horwitz EM; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University Department of Pediatrics, Atlanta, GA, USA., Feletti A; Department of Neurosurgery, NOCSAE Hospital of Modena, Modena, Italy., Pavesi G; Department of Neurosurgery, NOCSAE Hospital of Modena, Modena, Italy., Dominici M; Department of Medical and Surgical Sciences for Children and Adults, Division of Oncology, University-Hospital of Modena and Reggio Emilia, Modena, Italy. massimo.dominici@unimore.it.; Rigenerand Srl, Medolla, Modena, Italy. massimo.dominici@unimore.it.

Publikováno v: Cancer gene therapy [Cancer Gene Ther] 2020 Aug; Vol. 27 (7-8), pp. 558-570. Date of Electronic Publication: 2018 Nov 22.

1067 - Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER

Autor: Neri, G., Chiavelli, C., Trudu, L., Prapa, M., Golinelli, G., Pugliese, G., Silingardi, M., Rovesti, G., Grisendi, G., Bestagno, M., Spano, C., Benati, D., Recchia, A., Masciale, V., Bertolini, F., Dominici, M.

Publikováno v: In Cytotherapy May 2023 25(6) Supplement:S243-S244

Bioresorbable Nanostructured Chemical Sensor for Monitoring of pH Level In Vivo.

Autor: Corsi M; Dipartimento di Ingegneria dell'Informazione, Università di Pisa, via G. Caruso 16, Pisa, 56122, Italy., Paghi A; Dipartimento di Ingegneria dell'Informazione, Università di Pisa, via G. Caruso 16, Pisa, 56122, Italy., Mariani S; Dipartimento di Ingegneria dell'Informazione, Università di Pisa, via G. Caruso 16, Pisa, 56122, Italy., Golinelli G; Department of Medical and Surgical Sciences for Children & Adults, University-Hospital of Modena and Reggio Emilia, Via del Pozzo 71, Modena, 41124, Italy., Debrassi A; Surflay Nanotec GmbH, Max-Planck-Straße 3, 12489, Berlin, Germany., Egri G; Surflay Nanotec GmbH, Max-Planck-Straße 3, 12489, Berlin, Germany., Leo G; Department of Biomedical Metabolic and Neural Sciences, University of Modena and Reggio Emilia, via G. Campi 287, Modena, 41125, Italy., Vandini E; Department of Biomedical Metabolic and Neural Sciences, University of Modena and Reggio Emilia, via G. Campi 287, Modena, 41125, Italy., Vilella A; Department of Biomedical Metabolic and Neural Sciences, University of Modena and Reggio Emilia, via G. Campi 287, Modena, 41125, Italy., Dähne L; Surflay Nanotec GmbH, Max-Planck-Straße 3, 12489, Berlin, Germany., Giuliani D; Department of Biomedical Metabolic and Neural Sciences, University of Modena and Reggio Emilia, via G. Campi 287, Modena, 41125, Italy., Barillaro G; Dipartimento di Ingegneria dell'Informazione, Università di Pisa, via G. Caruso 16, Pisa, 56122, Italy.

Publikováno v: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2022 Aug; Vol. 9 (22), pp. e2202062. Date of Electronic Publication: 2022 May 26.

Engineered cellular immunotherapies in cancer and beyond.

Autor: Finck AV; Center for Cellular Immunotherapies, Perelman School of Medicine, and Parker Institute for Cancer Immunotherapy at University of Pennsylvania, Philadelphia, PA, USA. finckam@pennmedicine.upenn.edu.; Immunology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. finckam@pennmedicine.upenn.edu., Blanchard T; Center for Cellular Immunotherapies, Perelman School of Medicine, and Parker Institute for Cancer Immunotherapy at University of Pennsylvania, Philadelphia, PA, USA.; Pharmacology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Roselle CP; Center for Cellular Immunotherapies, Perelman School of Medicine, and Parker Institute for Cancer Immunotherapy at University of Pennsylvania, Philadelphia, PA, USA.; Pharmacology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Golinelli G; Center for Cellular Immunotherapies, Perelman School of Medicine, and Parker Institute for Cancer Immunotherapy at University of Pennsylvania, Philadelphia, PA, USA.; Laboratory of Cellular Therapy, Division of Oncology, Department of Medical and Surgical Sciences for Children & Adults, University-Hospital of Modena and Reggio Emilia, Modena, Italy., June CH; Center for Cellular Immunotherapies, Perelman School of Medicine, and Parker Institute for Cancer Immunotherapy at University of Pennsylvania, Philadelphia, PA, USA. cjune@upenn.edu.

Publikováno v: Nature medicine [Nat Med] 2022 Apr; Vol. 28 (4), pp. 678-689. Date of Electronic Publication: 2022 Apr 19.